Literature DB >> 21216865

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

Rafael López-Rojas1, Juan Domínguez-Herrera, Michael J McConnell, Fernando Docobo-Peréz, Younes Smani, María Fernández-Reyes, Luis Rivas, Jerónimo Pachón.   

Abstract

Acinetobacter baumannii (American Type Culture Collection strain 19606) acquires mutations in the pmrB gene during the in vitro development of resistance to colistin. The colistin-resistant strain has lower affinity for colistin, reduced in vivo fitness (competition index, .016), and decreased virulence, both in terms of mortality (0% lethal dose, 6.9 vs 4.9 log colony-forming units) and survival in a mouse model of peritoneal sepsis. These results may explain the low incidence and dissemination of colistin resistance in A. baumannii in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216865      PMCID: PMC3071218          DOI: 10.1093/infdis/jiq086

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Treatment of multiresistant Acinetobacter baumannii infections.

Authors:  Jerónimo Pachón; Jordi Vila
Journal:  Curr Opin Investig Drugs       Date:  2009-02

Review 2.  The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more.

Authors:  John S Gunn
Journal:  Trends Microbiol       Date:  2008-05-06       Impact factor: 17.079

3.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

4.  Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium.

Authors:  J S Gunn; S S Ryan; J C Van Velkinburgh; R K Ernst; S I Miller
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

5.  Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity.

Authors:  Chul Hee Choi; Sung Hee Hyun; Ji Young Lee; Jun Sik Lee; Yong Seok Lee; Soon Ae Kim; Jeong-Pil Chae; Seung Min Yoo; Je Chul Lee
Journal:  Cell Microbiol       Date:  2007-08-30       Impact factor: 3.715

6.  Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa.

Authors:  R A Moore; L Chan; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

7.  PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A.

Authors:  Samuel M Moskowitz; Robert K Ernst; Samuel I Miller
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

8.  Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.

Authors:  David M Livermore; Robert L R Hill; Hazel Thomson; André Charlett; Jane F Turton; Rachel Pike; Bharat C Patel; Rohini Manuel; Stephen Gillespie; Indran Balakrishnan; Stephen P Barrett; Nigel Cumberland; Mary Twagira
Journal:  Int J Antimicrob Agents       Date:  2009-11-11       Impact factor: 5.283

9.  The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

Authors:  María Fernández-Reyes; Manuel Rodríguez-Falcón; Cristina Chiva; Jerónimo Pachón; David Andreu; Luis Rivas
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

10.  Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.

Authors:  Raquel Valencia; Luis A Arroyo; Manuel Conde; Josefa M Aldana; María-José Torres; Felipe Fernández-Cuenca; José Garnacho-Montero; José M Cisneros; Carlos Ortíz; Jerónimo Pachón; Javier Aznar
Journal:  Infect Control Hosp Epidemiol       Date:  2009-03       Impact factor: 3.254

View more
  56 in total

1.  Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae.

Authors:  Fabio Arena; Lucia Henrici De Angelis; Antonio Cannatelli; Vincenzo Di Pilato; Marina Amorese; Marco Maria D'Andrea; Tommaso Giani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.

Authors:  Bianca Dößelmann; Matthias Willmann; Matthias Steglich; Boyke Bunk; Ulrich Nübel; Silke Peter; Richard A Neher
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia.

Authors:  Sami Hraiech; Antoine Roch; Hubert Lepidi; Thérèse Atieh; Gilles Audoly; Jean-Marc Rolain; Didier Raoult; Jean-Michel Brunel; Laurent Papazian; Fabienne Brégeon
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

4.  Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Authors:  Rafael López-Rojas; Michael J McConnell; Manuel Enrique Jiménez-Mejías; Juan Domínguez-Herrera; Felipe Fernández-Cuenca; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

Review 5.  Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?

Authors:  Cédric Abat; Pierre-Edouard Fournier; Marie-Thérèse Jimeno; Jean-Marc Rolain; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-28       Impact factor: 3.267

Review 6.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 7.  Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

8.  Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.

Authors:  Jean-Marc Rolain; Seydina M Diene; Marie Kempf; Gregory Gimenez; Catherine Robert; Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 9.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

10.  Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.

Authors:  Myung-Jin Choi; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.